SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001140361-16-054004
Filing Date
2016-02-18
Accepted
2016-02-18 18:44:15
Documents
1
Period of Report
2016-02-16

Document Format Files

Seq Description Document Type Size
1 FORM 4 doc1.html 4  
1 FORM 4 doc1.xml 4 4106
  Complete submission text file 0001140361-16-054004.txt   5505
Mailing Address 200 CONNELL DRIVE SUITE 1600 BERKELEY HEIGHTS NJ 07922
Business Address 200 CONNELL DRIVE SUITE 1600 BERKELEY HEIGHTS NJ 07922 800-208-3343
Edge Therapeutics, Inc. (Issuer) CIK: 0001472091 (see all company filings)

IRS No.: 264231384 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O MYOS CORPORATION 45 HORSEHILL ROAD, SUITE 106 CEDAR KNOLLS NJ 07927
Business Address
Einhorn Andrew J. (Reporting) CIK: 0001560685 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37568 | Film No.: 161439433